Richard V, Meunier F, Van der Auwera P, Dejace P, Daneau D, Klastersky J
Service de Médecine Interne, Institut Jules Bordet, Brussels, Belgium.
Eur J Epidemiol. 1988 Jun;4(2):242-5. doi: 10.1007/BF00144760.
Twenty-eight episodes of Streptococcus pneumoniae bacteremia occurring in 27 cancer patients hospitalized in the Institut Jules Bordet between July 1979 and April 1985 were reviewed. Ten patients had hematological malignancies and 17 had solid tumors (in 7 cases, of the lung). Forty-four per cent of the patients were neutropenic (less than 1000/microliters) and 36% of the patients were in septic shock. In 36% of the patients no clinical source of S. pneumoniae bacteremia could be found. Seventy-nine (21% patients) received empirical antibiotic treatment containing a beta-lactam. Two patients who did not receive any empirical treatment died within 12 hours. Overall, 11/27 patients died within the first week, and 8/27 died within the first three days. Mortality in neutropenic patients was not different from that in non-neutropenic patients. In comparison with a similar study performed previously in our institution, there was no difference in incidence, type of patient, source of bacteremia, or mortality.
回顾了1979年7月至1985年4月在朱尔斯·博尔代研究所住院的27例癌症患者中发生的28例肺炎链球菌菌血症病例。10例患者患有血液系统恶性肿瘤,17例患有实体瘤(7例为肺癌)。44%的患者中性粒细胞减少(低于1000/微升),36%的患者处于感染性休克状态。36%的患者未发现肺炎链球菌菌血症的临床来源。79例(21%的患者)接受了含β-内酰胺类的经验性抗生素治疗。2例未接受任何经验性治疗的患者在12小时内死亡。总体而言,27例患者中有11例在第一周内死亡,27例中有8例在头三天内死亡。中性粒细胞减少患者的死亡率与非中性粒细胞减少患者的死亡率无差异。与我们机构之前进行的一项类似研究相比,在发病率、患者类型、菌血症来源或死亡率方面没有差异。